Pharmaceutical Industry News

The Indian government proposes easier norms for drug approval processes, allowing applicants to begin studies after informing the regulator and halving import l

Natco Pharma is exploring opportunities beyond generic drugs for future growth, as explained by CEO and Vice Chairman Rajeev Nannapaneni. He detailed how Indian

The pharmaceutical industry is facing a significant challenge as over $500 billion in projected annual drug sales are at risk due to upcoming patent expirations

केंद्रीय औषधि मानक नियंत्रण संगठन (CDSCO) की जांच में हिमाचल प्रदेश में बनी 82 दवाओं सहित देशभर की 240 दवाओं के सैंपल फेल हो गए हैं, जिनमें से 52 सैंपल अकेले बद

Former President Donald Trump's executive order to separate combination childhood vaccines like MMR faces strong condemnation from public health experts and sig

India's pharmaceutical industry has achieved a historic milestone with a new drug approval, showcasing its transformation from an importer to a global leader in

AstraZeneca CEO Pascal Soriot urged Western drugmakers to adopt a "Chinese speed" approach to innovation, warning that Europe and the US risk being outpaced in

The article focuses on fostering new opportunities within the pharmaceutical industry in both the Greater Bay Area and across Asia.

Dr Reddy's Laboratories CEO Erez Israeli stated that increased US tariffs on generic medicines will lead to higher drug prices in India. He noted that relocatin

The Semaglutide situation has exposed systemic weaknesses in India's pharmaceutical industry, potentially proving costly for the country's generics sector.

Emcure Pharma is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals, taking full control to simplify ownership and sharpen strategic focus. Sami